v3.25.2
Consolidated Statements of Change in Shareholders’ Equity - USD ($)
Ordinary share
Previously Reported
Ordinary share
Reverse Recapitalization
Ordinary share
Additional paid-in capital
Previously Reported
Additional paid-in capital
Reverse Recapitalization
Additional paid-in capital
Retained earnings
Previously Reported
Retained earnings
Reverse Recapitalization
Retained earnings
Accumulated other comprehensive (loss) income
Previously Reported
Accumulated other comprehensive (loss) income
Reverse Recapitalization
Accumulated other comprehensive (loss) income
Non-controlling interest
Previously Reported
Non-controlling interest
Reverse Recapitalization
Non-controlling interest
Previously Reported
Reverse Recapitalization
Total
Balance at Mar. 31, 2022 $ 2,590 $ 7,908 $ 10,498 $ 1,102,505 $ (7,908) $ 1,094,597 $ 11,325,759 $ 11,325,759 $ (3,524) $ (3,524) $ 23,774 $ 23,774 $ 12,451,104 $ 12,451,104
Balance (in Shares) at Mar. 31, 2022 25,896,000 79,076,376 104,972,376                              
Net income (loss)                 1,986,119           154,551     2,140,670
Recognition of non-controlling interest from acquisition of subsidiaries                     2,590,000     2,590,000
Reclassification of redeemable ordinary shares from mezzanine to permanent equity                                  
Issuance of ordinary share upon the reverse recapitalization                                  
Foreign currency translation adjustments                 (25,336)     (550)     (25,886)
Balance at Mar. 31, 2023     $ 10,498     1,094,597     13,311,878     (28,860)     2,767,775     17,155,888
Balance (in Shares) at Mar. 31, 2023     104,972,376                              
Net income (loss)                 (1,373,504)           (587,452)     (1,960,956)
Recognition of non-controlling interest from acquisition of subsidiaries         381,947             182,599     564,546
Accretion from change in fair value of ordinary shares subject to possible redemption         (12,652)                 (12,652)
Shares issuance for partial settlement of contingent consideration for acquisition     $ 8     266,206                 266,214
Shares issuance for partial settlement of contingent consideration for acquisition (in Shares)     82,969                              
Reclassification of redeemable ordinary shares from mezzanine to permanent equity                                  
Issuance of ordinary share upon the reverse recapitalization                                  
Foreign currency translation adjustments                   (91,691)     3,810     (87,881)
Balance at Mar. 31, 2024     $ 10,506     1,730,098     11,938,374     (120,551)     2,366,732     $ 15,925,159
Balance (in Shares) at Mar. 31, 2024     105,055,345                             105,055,344 [1]
Net income (loss)                 5,587,625           (538,204)     $ 5,049,421
Recognition of non-controlling interest from acquisition of subsidiaries                                  
Shares issuance for partial settlement of contingent consideration for acquisition     $ 106     2,633,344                 2,633,450
Shares issuance for partial settlement of contingent consideration for acquisition (in Shares)     1,059,628                              
Reclassification of redeemable ordinary shares from mezzanine to permanent equity     $ 22     699,978                 700,000
Reclassification of redeemable ordinary shares from mezzanine to permanent equity (in Shares)     217,724                              
Acquisition of additional controlling interest of subsidiaries         (192,186)         2,030     (740,725)     (930,881)
Ordinary shares issued for conversion of convertible notes     $ 734     25,062,327                 $ 25,063,061
Ordinary shares issued for conversion of convertible notes (in Shares)     7,338,887                             120,000,000
Issuance of ordinary share upon the reverse recapitalization     $ 628     (10,081,840)                 $ (10,081,212)
Issuance of ordinary share upon the reverse recapitalization (in Shares)     6,276,394                              
Incremental fair value of warrants upon the reverse recapitalization         12,014     (12,014)            
Merger transaction cost           (1,713,953)                 (1,713,953)
Stock-based compensation     $ 200     (200)                
Stock-based compensation (in Shares)     2,000,000                              
Foreign currency translation adjustments                 296,833     15,384     312,217
Balance at Mar. 31, 2025     $ 12,196     $ 18,149,582     $ 17,513,985     $ 178,312     $ 1,103,187     $ 36,957,262
Balance (in Shares) at Mar. 31, 2025     121,947,978                             121,947,978 [1]
[1] Giving retroactive effect to reverse recapitalization effected on February 13, 2025.